Andrew Moin

Insider Reports History

Location
Sioux Falls, SD
Signature
/s/ Andrew Moin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Moin:

Company Role Class Num Shares Value Price $ Report Date Ownership
SAB Biotherapeutics, Inc. Director Common Stock 2,198,457 $3,847,299 $1.75 29 Sep 2025 Indirect
SAB Biotherapeutics, Inc. Director Series B Convertible Preferred Stock 211,100 29 Sep 2025 Indirect
SAB Biotherapeutics, Inc. Director Warrants (right to buy) 114,250 22 Jul 2025 Indirect

Insider Reports Filed by Andrew Moin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SABS SAB Biotherapeutics, Inc. 29 Sep 2025 2 +$3,045,000 4 Director 01 Oct 2025, 16:35
SABS SAB Biotherapeutics, Inc. 22 Jul 2025 3 $0 4 Director 24 Jul 2025, 16:30
SABS SAB Biotherapeutics, Inc. 24 Nov 2023 3 -$2,889,000 4 Director 28 Nov 2023, 16:05
SABS SAB Biotherapeutics, Inc. 10 Nov 2023 1 +$13,269,000 4/A Director 15 Nov 2023, 21:10
SABS SAB Biotherapeutics, Inc. 23 Oct 2023 2 +$16,269,000 4 Director 24 Oct 2023, 17:30
SABS SAB Biotherapeutics, Inc. 02 Oct 2023 0 $0 3 Director 10 Oct 2023, 16:05